A rare case of pulmonary tuberculosis with simultaneous pulmonary and skin sarcoidosis: a case report.

Kornelija Mise
Kornelija Mise
University of Split
Ivana Goic-Barisic
Ivana Goic-Barisic
University of Split
Igor Barisic
Igor Barisic
University of Split
Marija Tonkic
Marija Tonkic
University Hospital Split

Cases J 2010 Jan 13;3:24. Epub 2010 Jan 13.

Department of Clinical Microbiology and School of Medicine University of Split, Split, Croatia.

Background: Tuberculosis and sarcoidosis are chronic diseases that rarely occur concomitantly. Sarcoidosis is a multisystem granulomatous disorder characterized pathologically by the presence of non-caseating granulomas in involved tissues. Tuberculosis is infectious disease caused by Mycobacterium tuberculosis characterized by granulomas with caseous necrosis.

Case Presentation: We present a case of 43-year-old female refugee from Kosovo with microbiological confirmation of pulmonary tuberculosis and pulmonary and skin sarcoidosis at the same time. Three weeks after corticosteroid therapy for pulmonary sarcoidosis was introduced, positive finding of mycobacterium culture of bronchial aspirate was observed. Based on these results, corticosteroid therapy was excluded and antituberculous therapy was introduced for six months. In the meantime, new nodes on face and nose appeared and skin sarcoidosis was diagnosed. The patient was given corticosteroids and colchicine according to the skin and pulmonary sarcoidosis therapy recommendation.

Conclusion: The authors of this study suggest that in cases when there is a dilemma in diagnosis between tuberculosis and sarcoidosis we should advance with corticosteroid therapy until we have microbiological confirmation of mycobacterium culture. This case is remarkable because this is a third described case of sarcoidosis and tuberculosis together (the first reported in Asia, the second in South Africa), and to authors knowledge, this is a first case report in Europe.
PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
Source Status
http://dx.doi.org/10.1186/1757-1626-3-24DOI ListingPossible
January 2010
5 Reads

Similar Publications

Asymptomatic stage I sarcoidosis complicated by pulmonary tuberculosis: a case report.

J Med Case Rep 2008 Jul 7;2:226. Epub 2008 Jul 7.

3rd Department of Medicine, University of Athens, Medical School, 'Sotiria' General Hospital, Athens, Greece.

Introduction: Sarcoidosis is a multisystem granulomatous disorder characterized pathologically by the presence of non-caseating granulomas in involved tissues. Depressed cellular immunity predisposes patients to infections with certain intracellular organisms, mostly fungi, Mycobacterium tuberculosis and Nocardia species. As these infections are mainly insidious and difficult to differentiate from the underlying disease, a possible misdiagnosis may lead to fatal complications for the patient. Read More

View Article
July 2008

Sarcoidosis following Mycobacterium tuberculosis infection: Coincidence or consequence.

Respir Med Case Rep 2013 3;9:11-4. Epub 2013 May 3.

Catharina Hospital Eindhoven, Department of Respiratory Medicine, The Netherlands.

We describe the case of a 47-year-old Caucasian male patient who developed sarcoidosis 18 months after he was diagnosed with pulmonary tuberculosis for which he was treated according to guidelines. The presentation of sarcoidosis was very similar to his first presentation when he was diagnosed with tuberculosis. Mycobacterium tuberculosis as a possible aetiological agent in sarcoidosis has been point of debate since many years and has been studied thoroughly. Read More

View Article
June 2015

Common features of tuberculosis and sarcoidosis.

Int J Mycobacteriol 2016 Dec 9;5 Suppl 1:S240-S241. Epub 2016 Nov 9.

Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Despite the availability of novel therapeutic approaches, TB is considered as one of the leading causes of death due to infectious diseases worldwide. Alveolar macrophages are the first line of defense against M. Read More

View Article
December 2016

[Granulomatous diseases and pathogenic microorganism].

Kekkaku 2008 Feb;83(2):115-30

Clinical Research Center, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan.

Granuloma formation is a chronic inflammatory reaction where macrophage system and other inflammatory cells are involved. After some antigen exposure and processing, T cells, macrophages, epithelioid cells, and giant cell are activated, and granulomas are formed. Granuloma is considered as a defense mechanism against antigens, which stay in the organs without inactivation. Read More

View Article
February 2008